Sectoral Asset Management Inc Zentalis Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$9.84 - $20.13 $3.73 Million - $7.63 Million	-379,170 Reduced 98.1%	7,355 $111,000
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $2.99 Million - $4.31 Million	152,525 Added 65.18%	386,525 $7.75 Million
Q1 2023 May 12, 2023	BUY	$16.14 - $24.94 $532,620 - $823,020	33,000 Added 16.42%	234,000 $4.02 Million
Q4 2022 Feb 10, 2023	BUY	$18.07 - $25.6 $2.55 Million - $3.61 Million	141,000 Added 235.0%	201,000 $4.05 Million
Q3 2022 Nov 10, 2022	BUY	$20.23 - $31.73 $1.21 Million - $1.9 Million	60,000 New	60,000 $1.3 Million
Q4 2020 Feb 12, 2021	SELL	$31.71 - $57.97 $17.7 Million - $32.3 Million	-556,712 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$27.03 - $47.97 $11.2 Million - $19.8 Million	412,512 Added 286.07%	556,712 $18.2 Million
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $3.35 Million - $7.9 Million	144,200 New	144,200 $6.92 Million

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.